Mental Health Clinics in Lederach, PA Accepting Medicare
2 Mental Health Clinics found. Showing 1 - 2
 Brightside Billing, Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 701 Cross Road, Lederach, PA 19450 Phone: 215-264-2272 Fax: 215-392-8540 |
Brightside Counseling Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 701 Cross Road, Lederach, PA 19450 Phone: 215-264-2272 Fax: 215-256-1112 |
News Archive
New AI-based tool helps clinicians understand and better predict adverse effects of COVID-19
The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes.
New predictive medicine product for hereditary pancreatic and related cancers
Myriad Genetics, Inc. today announced the launch of PANEXIA™, a predictive medicine product for hereditary pancreatic and related cancers. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. PANEXIA, Myriad's ninth molecular diagnostic product, is the second product launched by the Company this year.
Review examines what influences HIV-positive patients to stay on antiretroviral drugs in Africa
An international team of researchers have carried out a review of the evidence examining what influences people who are HIV positive to go to health services and then stay on antiretroviral drugs in Africa.
Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19
In an attempt to study the safety and effectiveness of sotrovimab in more vulnerable patients suffering from mild to moderate symptoms of COVID-19, a multinational team of researchers conducted the COVID-19 Monoclonal antibody Efficacy Trial-Intent to Care Early (COMET-ICE) trial.
UNC and Cell Microsystems receive NIH Phase I SBIR contract to develop HIV diagnostic assay
The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced they have received an approximately $283,000, 12-month Phase I Small Business Innovation and Research contract from the National Institutes of Health to develop an automated platform to quantify the latent HIV reservoir.
› Verified 7 days ago